Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Greenville Hospital System
795
mi
from 02139
Greenville, SC
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Greenville Hospital System
795
mi
from 02139
Greenville, SC
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Cardiothoracic & Vascular Surgeons
1690
mi
from 02139
Austin, TX
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Cardiothoracic & Vascular Surgeons
1690
mi
from 02139
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Methodist Medical Center
1548
mi
from 02139
Dallas, TX
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Methodist Medical Center
1548
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Dallas VA Medical Center
1547
mi
from 02139
Dallas, TX
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Dallas VA Medical Center
1547
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Sentara Vascular Specialists
470
mi
from 02139
Norfolk, VA
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Sentara Vascular Specialists
470
mi
from 02139
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated:  4/12/2016
Hospital Virgen de la Salud
3402
mi
from 02139
Toledo,
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Status: Enrolling
Updated: 4/12/2016
Hospital Virgen de la Salud
3402
mi
from 02139
Toledo,
Click here to add this to my saved trials
Safety Study of Pyridostigmine in Heart Failure
Augmentation of Parasympathetic Signaling With Pyridostigmine in Heart Failure
Status: Enrolling
Updated:  4/13/2016
New York University Langone Medical Center
185
mi
from 02139
New York, NY
Safety Study of Pyridostigmine in Heart Failure
Augmentation of Parasympathetic Signaling With Pyridostigmine in Heart Failure
Status: Enrolling
Updated: 4/13/2016
New York University Langone Medical Center
185
mi
from 02139
New York, NY
Click here to add this to my saved trials
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation: A Pilot Trial of the "Dynamic Thoracic Impedance Bed Rest Test"
Status: Enrolling
Updated:  4/13/2016
University of Kansas Medical Center
1254
mi
from 02139
Kansas City, KA
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation: A Pilot Trial of the "Dynamic Thoracic Impedance Bed Rest Test"
Status: Enrolling
Updated: 4/13/2016
University of Kansas Medical Center
1254
mi
from 02139
Kansas City, KA
Click here to add this to my saved trials
To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease
A Clinical Study of the TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Diseases for Non-Surgical Candidates Under the Physician Sponsored IDE.
Status: Enrolling
Updated:  4/13/2016
Stanford University School of Medicine
2687
mi
from 02139
Stanford, CA
To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease
A Clinical Study of the TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Diseases for Non-Surgical Candidates Under the Physician Sponsored IDE.
Status: Enrolling
Updated: 4/13/2016
Stanford University School of Medicine
2687
mi
from 02139
Stanford, CA
Click here to add this to my saved trials
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated:  4/15/2016
Novartis Investigative Site
1015
mi
from 02139
Jacksonville, FL
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated: 4/15/2016
Novartis Investigative Site
1015
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated:  4/15/2016
Novartis
180
mi
from 02139
New York, NY
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Status: Enrolling
Updated: 4/15/2016
Novartis
180
mi
from 02139
New York, NY
Click here to add this to my saved trials
The Congestive Heart Failure Adherence Redesign Trial
Reduction in Hospitalizations in Low-Income Patients With Heart Failure
Status: Enrolling
Updated:  4/15/2016
Rush University Medical Center
849
mi
from 02139
Chicago, IL
The Congestive Heart Failure Adherence Redesign Trial
Reduction in Hospitalizations in Low-Income Patients With Heart Failure
Status: Enrolling
Updated: 4/15/2016
Rush University Medical Center
849
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated:  4/15/2016
University of North Carolina at Chapel Hill
610
mi
from 02139
Chapel Hill, NC
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated: 4/15/2016
University of North Carolina at Chapel Hill
610
mi
from 02139
Chapel Hill, NC
Click here to add this to my saved trials
THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring
This Study Will Investigate the Association Between a Set of Single Nucleotide Polymorphisms (SNPs) and Atrial Fibrillation in Patients at High Risk of Developing Atrial Fibrillation. The SNPs Investigated Will Have Been Previously Shown to be Associated With the Atrial Fibrillation.
Status: Enrolling
Updated:  4/18/2016
Scripps Clinic
2577
mi
from 02139
La Jolla, CA
THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring
This Study Will Investigate the Association Between a Set of Single Nucleotide Polymorphisms (SNPs) and Atrial Fibrillation in Patients at High Risk of Developing Atrial Fibrillation. The SNPs Investigated Will Have Been Previously Shown to be Associated With the Atrial Fibrillation.
Status: Enrolling
Updated: 4/18/2016
Scripps Clinic
2577
mi
from 02139
La Jolla, CA
Click here to add this to my saved trials
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated:  4/18/2016
University of Maryland
357
mi
from 02139
Baltimore, MD
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated: 4/18/2016
University of Maryland
357
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated:  4/18/2016
Minneapolis Medical Research Foundation
1118
mi
from 02139
Minneapolis, MN
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated: 4/18/2016
Minneapolis Medical Research Foundation
1118
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated:  4/18/2016
Manassas Clinical Research Center
417
mi
from 02139
Manassas, VA
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
Status: Enrolling
Updated: 4/18/2016
Manassas Clinical Research Center
417
mi
from 02139
Manassas, VA
Click here to add this to my saved trials
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
Systemic Effects of Aprotinin During Cardiac Surgery/ Long Term Death Rates
Status: Enrolling
Updated:  4/18/2016
SUNY Upstate Medical University
260
mi
from 02139
Syracuse, NY
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
Systemic Effects of Aprotinin During Cardiac Surgery/ Long Term Death Rates
Status: Enrolling
Updated: 4/18/2016
SUNY Upstate Medical University
260
mi
from 02139
Syracuse, NY
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Florida
1078
mi
from 02139
Gainesville, FL
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Florida
1078
mi
from 02139
Gainesville, FL
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Georgia Health Sciences University
861
mi
from 02139
Augusta, GA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Georgia Health Sciences University
861
mi
from 02139
Augusta, GA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Tulane University Health Science Center
1356
mi
from 02139
New Orleans, LA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Tulane University Health Science Center
1356
mi
from 02139
New Orleans, LA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Maryland School of Medicine
357
mi
from 02139
Baltimore, MD
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Maryland School of Medicine
357
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Henry Ford Hospital
610
mi
from 02139
Detroit, MI
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Henry Ford Hospital
610
mi
from 02139
Detroit, MI
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Mayo Clinic College of Medicine
1079
mi
from 02139
Rochester, MN
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Mayo Clinic College of Medicine
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Montefiore Medical Center
176
mi
from 02139
Bronx, NY
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Montefiore Medical Center
176
mi
from 02139
Bronx, NY
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Duke University
601
mi
from 02139
Durham, NC
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Duke University
601
mi
from 02139
Durham, NC
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Hospital of the University of Pennsylvania
270
mi
from 02139
Philadelphia, PA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Hospital of the University of Pennsylvania
270
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Vanderbilt University
939
mi
from 02139
Nashville, TN
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Vanderbilt University
939
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Texas Medical Branch
1594
mi
from 02139
Galveston, TX
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Texas Medical Branch
1594
mi
from 02139
Galveston, TX
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Intermountain Medical Center
2093
mi
from 02139
Murray, UT
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Intermountain Medical Center
2093
mi
from 02139
Murray, UT
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Utah Health Care
2091
mi
from 02139
Salt Lake City, UT
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Utah Health Care
2091
mi
from 02139
Salt Lake City, UT
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Marshfield Clinical Research Foundation
966
mi
from 02139
Marshfield, WI
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Marshfield Clinical Research Foundation
966
mi
from 02139
Marshfield, WI
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Alabama at Birmingham
1052
mi
from 02139
Birmingham, AL
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Alabama at Birmingham
1052
mi
from 02139
Birmingham, AL
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of California at San Francisco
2692
mi
from 02139
San Francisco, CA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of California at San Francisco
2692
mi
from 02139
San Francisco, CA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Washington University School of Medicine
1036
mi
from 02139
St. Louis, MO
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Washington University School of Medicine
1036
mi
from 02139
St. Louis, MO
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Mount Sinai School of Medicine
182
mi
from 02139
New York, NY
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Mount Sinai School of Medicine
182
mi
from 02139
New York, NY
Click here to add this to my saved trials
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
Status: Enrolling
Updated:  4/19/2016
University Hospital
1763
mi
from 02139
San Antonio, TX
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
Status: Enrolling
Updated: 4/19/2016
University Hospital
1763
mi
from 02139
San Antonio, TX
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
MedStar Washington Hospital Center
392
mi
from 02139
Washington,
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
MedStar Washington Hospital Center
392
mi
from 02139
Washington,
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
Emory University Hospital
929
mi
from 02139
Atlanta, GA
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
Emory University Hospital
929
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
Northwestern University Centers for Heart Failure Therapy
847
mi
from 02139
Chicago, IL
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
Northwestern University Centers for Heart Failure Therapy
847
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
Stony Brook Heart Institute
394
mi
from 02139
Stony Brook, NY
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
Stony Brook Heart Institute
394
mi
from 02139
Stony Brook, NY
Click here to add this to my saved trials
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated:  4/19/2016
Hospital of the University of Pennsylvania, Heart Failure and Transplant Program
270
mi
from 02139
Philedelphia, PA
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure
Status: Enrolling
Updated: 4/19/2016
Hospital of the University of Pennsylvania, Heart Failure and Transplant Program
270
mi
from 02139
Philedelphia, PA
Click here to add this to my saved trials
Stereotactic Body Radiotherapy for Spine Tumors
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Spine Metastases and Primary Spine Tumors
Status: Enrolling
Updated:  4/20/2016
St. John's Mercy Medical Center
1045
mi
from 02139
St. Louis, MO
Stereotactic Body Radiotherapy for Spine Tumors
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Spine Metastases and Primary Spine Tumors
Status: Enrolling
Updated: 4/20/2016
St. John's Mercy Medical Center
1045
mi
from 02139
St. Louis, MO
Click here to add this to my saved trials
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Demonstration of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Antiplatelet Effect of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Status: Enrolling
Updated:  4/20/2016
Sinai Hospital of Baltimore (Sinai Center for Thrombosis Research)
mi
from 02139
Baltimore, MD
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Demonstration of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Antiplatelet Effect of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Status: Enrolling
Updated: 4/20/2016
Sinai Hospital of Baltimore (Sinai Center for Thrombosis Research)
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated:  4/21/2016
Northside Vascular Surgery
934
mi
from 02139
Atlanta, GA
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated: 4/21/2016
Northside Vascular Surgery
934
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated:  4/21/2016
Rex Healthcare
608
mi
from 02139
Raleigh, NC
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated: 4/21/2016
Rex Healthcare
608
mi
from 02139
Raleigh, NC
Click here to add this to my saved trials
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated:  4/21/2016
Turkey Creek Medical Center
815
mi
from 02139
Knoxville, TN
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
Volcano Crux Vena Cava Filter Registry
Status: Enrolling
Updated: 4/21/2016
Turkey Creek Medical Center
815
mi
from 02139
Knoxville, TN
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
1247
mi
from 02139
Moblie, AL
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
1247
mi
from 02139
Moblie, AL
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
2583
mi
from 02139
Costa Mesa, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
2583
mi
from 02139
Costa Mesa, CA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
2590
mi
from 02139
Fresno, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
2590
mi
from 02139
Fresno, CA
Click here to add this to my saved trials